Turning Point Brands reported Modern Oral gross revenue soaring 149% to $87.0 million and total net sales climbing 22.6% to $142.9 million, while diluted EPS fell to $0.18 versus a $0.43 consensus. The miss underscores profit pressure despite rapid growth, signaling valuation risk for investors.
Key Highlights
- Total consolidated net sales rose 22.6% to $142.9 million
- Adjusted EBITDA fell 50% to $15.2 million
- Net income dropped 75.2% to $3.6 million
Turning Point Brands (NYSE: TPB) posted a 149% surge in Modern Oral gross revenue to $87.0 million in the second quarter, lifting total consolidated net sales 22.6% to $142.9 million. Investors see the revenue explosion as a sign of market‑share gains, yet the earnings miss raises concerns over cost structure and profitability.
149% Modern Oral Revenue Jump
Modern Oral’s $87.0 million gross revenue jump anchored the quarter’s headline growth, yet earnings pressure persisted. Adjusted diluted EPS of $0.23 contrasted sharply with the $0.43 consensus estimate, highlighting a profitability gap that analysts flagged. Gross profit rose 40.6% to $93.7 million, but a tariff‑related cost adjustment reduced the figure to $81.5 million, tempering headline gains.
The disparity between top‑line expansion and bottom‑line performance suggests that the company must balance rapid sales growth with margin discipline, especially as investors weigh the near‑term earnings miss against the longer‑term growth trajectory.
Segment Wins and Losses
Stoker’s products, which comprise roughly three‑quarters of TPB’s sales, saw net sales climb 54.5% to $107.6 million, driven by a three‑digit surge in Modern Oral sales. Conversely, the Zig‑Zag segment’s net sales fell 24.8% to $35.4 million, with gross profit slipping 2.1% to $22.6 million, but its gross margin improved to 57.3% from 49.1% as product mix shifted. These divergent trends illustrate that while Modern Oral fuels top‑line momentum, legacy categories remain vulnerable, a balance that could strain overall profitability if not managed.
Liquidity Cushion and Debt Profile
Cash on hand reached $268.3 million, while net debt stood at $31.7 million, leaving total liquidity at $339.0 million, inclusive of $70.7 million available under an asset‑backed revolving credit facility. SG&A expenses surged 91.1% to $76.9 million, reflecting intensified Modern Oral sales and marketing spend. The strong cash position offsets the steep rise in operating costs, yet the widening expense base could erode earnings if revenue growth stalls.
Maintaining a strong liquidity buffer is important for funding ongoing brand expansion and absorbing short‑term earnings volatility, especially given the company’s recent earnings shortfall.
Outlook and Upcoming Earnings Call
Adjusted EBITDA for the year is expected to fall between $70 million and $90 million, reflecting continued investment in sales, marketing, and trade promotions.
Peers Moving on This News
- Philip Morris International Inc (PM) down 1.3%
- Altria Group Inc (MO) down 0.8%
- Universal Corp (UVV) up 0.8%
Analysis based on the Form 8-K filed 4 August 2026; figures verified against the filing and live market data.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.






Please wait processing your request...